Jason Kwah, MD, MSc
Assistant Professor AdjunctCards
About
Research
Publications
2024
Improving Cefazolin Administration for Surgical Prophylaxis in Reported Penicillin Allergy: A Retrospective Study of a Health System Intervention
Belmont A, Son M, Hyman J, You L, Su C, Kashyap N, Topal J, McManus D, Martinello R, Kwah J. Improving Cefazolin Administration for Surgical Prophylaxis in Reported Penicillin Allergy: A Retrospective Study of a Health System Intervention. Journal Of Allergy And Clinical Immunology Global 2024, 100377. DOI: 10.1016/j.jacig.2024.100377.Peer-Reviewed Original ResearchPenicillin allergy labelHospital-wide guidelinesSurgical site infectionAllergy labelsSurgical patientsSevere allergic reactionsSurgical prophylaxisSite infectionAssociated with increased rates of surgical site infectionRate of surgical site infectionMulti-drug resistant infectionsAllergic reactionsPrevent surgical site infectionsFirst-line antibioticsFirst-line prophylaxisAdministration of cefazolinAssociated with increased ratesRetrospective cohort studyGuideline-directed therapyAdult surgical patientsPre-intervention groupPost-intervention groupPenicillin allergyPerioperative outcomesCefazolin administrationDiagnosis and Clinical Management of Drug Allergies in Obstetrics and Gynecology: An Expert Review
Burn M, Kwah J, Son M. Diagnosis and Clinical Management of Drug Allergies in Obstetrics and Gynecology: An Expert Review. American Journal Of Obstetrics And Gynecology 2024 PMID: 39490659, DOI: 10.1016/j.ajog.2024.10.025.Peer-Reviewed Original ResearchPenicillin allergyAntibiotic allergyAllergy evaluationDrug allergySkin testOral challengePregnant patientsObstetrician-gynecologistsAntibiotic useAssociated with increased cesarean deliveryAllergy testingGroup B streptococcus sepsisPatient historyNeonatal length of stayManagement of drug allergyIncreased length of hospital stayUnverified penicillin allergyLength of hospital stayFirst-line therapyFirst line antibioticsInduction of drug toleranceHigh-risk patientsSurgical site infectionIncreased surgical site infectionAdministration of antibioticsThe Cost of Developing and Implementing an Antepartum Referral Program for Penicillin Allergy Evaluation at a Single Academic Tertiary Care Hospital
Burn M, Xu X, Kwah J, Liao J, Son M. The Cost of Developing and Implementing an Antepartum Referral Program for Penicillin Allergy Evaluation at a Single Academic Tertiary Care Hospital. American Journal Of Perinatology 2024, 41: 1290-1297. PMID: 38423122, DOI: 10.1055/a-2278-9279.Peer-Reviewed Original ResearchCost of careReferral programLong-term cost benefitsPenicillin allergyAntibiotic costsAntibiotic stewardshipPregnant individualsProgram developmentAcademic tertiary care hospitalCompare costs of carePenicillin allergy evaluationShort-term costsTertiary care hospitalDelivery hospitalizationsResource utilization dataNo significant differenceNonreferred patientsCare hospitalUtilization dataAllergy evaluationBivariate testsStudy groupEducational initiativesPregnancy periodProgram costsValidating PEN-FAST in Reported Penicillin Allergies in Pregnancy to Enhance De-Labeling
You L, Liao J, Su C, Burn M, Son M, Kwah J. Validating PEN-FAST in Reported Penicillin Allergies in Pregnancy to Enhance De-Labeling. Journal Of Allergy And Clinical Immunology 2024, 153: ab155. DOI: 10.1016/j.jaci.2023.11.510.Peer-Reviewed Original ResearchPerioperative Hypersensitivity Evaluation: Too-Often Overlooked but Effective at Promoting the Safe Passage of Future Procedures
Liao J, Belmont A, Kwah J. Perioperative Hypersensitivity Evaluation: Too-Often Overlooked but Effective at Promoting the Safe Passage of Future Procedures. Journal Of Allergy And Clinical Immunology 2024, 153: ab167. DOI: 10.1016/j.jaci.2023.11.544.Peer-Reviewed Original Research
2023
DIAGNOSING THE UNCOMMON: BULLOUS PEMPHIGOID PRESENTING AS ECZEMATOUS DERMATITIS AND SEVERE PRURITIS
You L, Kwah J, Cohen J, Wong K. DIAGNOSING THE UNCOMMON: BULLOUS PEMPHIGOID PRESENTING AS ECZEMATOUS DERMATITIS AND SEVERE PRURITIS. Annals Of Allergy Asthma & Immunology 2023, 131: s189-s190. DOI: 10.1016/j.anai.2023.08.584.Peer-Reviewed Original ResearchAtopic dermatitisBullous pemphigoidSevere pruritusVariable clinical presentationSkin lesionsEczematous dermatitisCases of BPMonths of therapyHistory of asthmaSubset of patientsElevated IgG antibodiesSevere pruritisTense bullaeTopical corticosteroidsAllergic rhinitisPersistent pruritusAppropriate patientsInitial presentationScaly rashClinical presentationRare entityFinal diagnosisIgG antibodiesRare conditionCommon conditionEvaluating the PEN-FAST Clinical Decision-making Tool to Enhance Penicillin Allergy Delabeling
Su C, Belmont A, Liao J, Kuster J, Trubiano J, Kwah J. Evaluating the PEN-FAST Clinical Decision-making Tool to Enhance Penicillin Allergy Delabeling. JAMA Internal Medicine 2023, 183: 883-885. PMID: 37338869, PMCID: PMC10282954, DOI: 10.1001/jamainternmed.2023.1572.Peer-Reviewed Original ResearchDrug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management
Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management. Journal Of The American Academy Of Dermatology 2023, 90: 911-926. PMID: 37516356, DOI: 10.1016/j.jaad.2023.02.073.Peer-Reviewed Original ResearchSevere cutaneous adverse reactionsCutaneous adverse reactionsSystemic symptomsDrug reactionsAdverse reactionsDifferential diagnosisDrug-induced hypersensitivity syndrome/drug reactionDrug-induced hypersensitivity syndromeDiHS/DRESSVisceral organ involvementSteroid-sparing agentCornerstone of managementFirst-line therapyEvidence-based overviewSystemic corticosteroidsHypersensitivity syndromeImmediate discontinuationOrgan involvementRisk stratificationAutoimmune diseasesAdjunctive testNeoplastic disordersDiagnostic criteriaLongitudinal evaluationDiagnosisDrug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis
Wei B, Fox L, Kaffenberger B, Korman A, Micheletti R, Mostaghimi A, Noe M, Rosenbach M, Shinkai K, Kwah J, Phillips E, Bolognia J, Damsky W, Nelson C. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis. Journal Of The American Academy Of Dermatology 2023, 90: 885-908. PMID: 37516359, DOI: 10.1016/j.jaad.2023.02.072.Peer-Reviewed Original ResearchSevere cutaneous adverse reactionsDiHS/DRESSClinicopathological featuresSystemic symptomsDrug reactionsDrug-induced hypersensitivity syndrome/drug reactionDrug-induced hypersensitivity syndromePart I. EpidemiologyVisceral organ involvementCutaneous adverse reactionsRisk of relapseHypersensitivity syndromeOrgan involvementI. EpidemiologyOrgan dysfunctionSignificant morbidityAutoimmune diseasesAdverse reactionsDrug exposureT cellsCommon triggerImmune systemPathogenesisEosinophiliaMedical education activitiesPregnant Patients with a Documented History of Penicillin Allergy and Associated Maternal and Neonatal Outcomes at a Tertiary Care Center
Azmy V, Lundsberg L, Culhane J, Kwah J, Partridge C, Son M. Pregnant Patients with a Documented History of Penicillin Allergy and Associated Maternal and Neonatal Outcomes at a Tertiary Care Center. American Journal Of Perinatology 2023, 41: e2051-e2057. PMID: 37211008, DOI: 10.1055/a-2096-5002.Peer-Reviewed Original ResearchPenicillin allergy historyNon-β-lactam antibioticsPenicillin allergyNeonatal outcomesPregnant patientsAllergy historyPregnant individualsElectronic medical recordsMedical recordsMultivariable analysisPostpartum endometritisHigh riskLactam antibioticsSignificant differencesBad obstetric outcomeRetrospective cohort studyTertiary care centerPostnatal hospital stayWeeks of gestationLarge academic hospitalAssociated maternalEligible deliveriesHospital stayMaternal outcomesObstetric outcomes
Academic Achievements & Community Involvement
News
News
- December 14, 2023
Solving the Drug Allergy Puzzle: A Q&A With Ami Belmont
- October 12, 2023
Welcome New Staff, Faculty, Postdocs & Postgrads! (October 2023)
- April 17, 2023
Yale Allergy & Immunology Presents at AAAAI
- October 13, 2022
Discoveries & Impact (October 2022)